Immunogenicity 11226
Sample ID
3716
Response
Negative
Tumor Type
Melanoma
Gene Symbol
WDR91
Transcript ID
None
HLA INFO
B*15:01
TCR INFO
No TCR info found!
Full length protein sequence (792 aa)
MAEAV
1
ERTDE
6
LVREY
11
LLFRG
16
FTHTL
21
RQLDA
26
EIKAD
31
KEKGF
36
RVDKI
41
VDQLQ
46
QLMQV
51
YDLAA
56
LRDYW
61
SYLER
66
RLFSR
71
LEDIY
76
RPTIH
81
KLKTS
86
LFRFY
91
LVYTI
96
QTNRN
101
DKAQE
106
FFAKQ
111
ATELQ
116
NQAEW
121
KDWFV
126
LPFLP
131
SPDTN
136
PTFAT
141
YFSRQ
146
WADTF
151
IVSLH
156
NFLSV
161
LFQCM
166
PVPVI
171
LNFDA
176
ECQRT
181
NQVQE
186
ENEVL
191
RQKLF
196
ALQAE
201
IHRLK
206
KEEQQ
211
PEEEE
216
ALVQH
221
KLPPY
226
VSNMD
231
RLGDS
236
ELAMV
241
CSQRN
246
ASLSQ
251
SPRVG
256
FLSSL
261
LPQSK
266
KSPSR
271
LSPAQ
276
GPPQP
281
QSSAK
286
KESFG
291
GQGTK
296
GKDPT
301
SGAKD
306
GKSLL
311
SGLAT
316
GESGW
321
SQHRQ
326
RRLQD
331
HGKER
336
KELFS
341
TTTSQ
346
CAEKK
351
PEASG
356
PEAEP
361
CPELH
366
TEPVE
371
PLTRA
376
SSAGP
381
EGGGV
386
RPEQP
391
FIVLG
396
QEEYG
401
EHHSS
406
IMHCR
411
VDCSG
416
RRVAS
421
LDVDG
426
VIKVW
431
SFNPI
436
MQTKA
441
SSISK
446
SPLLS
451
LEWAT
456
KRDRL
461
LQFQW
466
APSRA
471
RPHGK
476
WLPLL
481
LLGSG
486
VGTVR
491
LYDTE
496
AKKNL
501
CEINI
506
NDNMP
511
RIQPQ
516
DQSAP
521
SLCGQ
526
AEGLT
531
QAHVC
536
CRILS
541
LACSP
546
NGASF
551
VCSAA
556
APSLT
561
SQVDF
566
SAPDI
571
GSKGM
576
NQVPG
581
RLLLW
586
DTKTM
591
KQQLQ
596
FSLDP
601
EPIAI
606
NCTAF
611
NHNGN
616
LLVTG
621
AADGV
626
IRLFD
631
MQQHE
636
CAMSW
641
RAHYG
646
EVYSV
651
EFSYD
656
ENTVY
661
SIGED
666
GKFIQ
671
WNIHK
676
SGLKV
681
SEYSL
686
PSDAT
691
GPFVL
696
SGYSG
701
YKQVQ
706
VPRGR
711
LFAFD
716
SEGNY
721
MLTCS
726
ATGGV
731
IYKLG
736
GDEKV
741
LESCL
746
SLGGH
751
RAPVV
756
TVDWS
761
TAMDC
766
GTCLT
771
ASMDG
776
KIKLT
781
TLLAH
786
KA
791
Mutation Information
DNA mutation:
None
Peptide Range:
25 ~ 49
Mut AA position:
37 (13 in Wild Type peptide)
Alignment
Wild Type:
"LRQLDAEIKADKEKGFRVDKIVDQL
||||||||||||.||||||||||||
Mutant:
LRQLDAEIKADKKKGFRVDKIVDQL"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) WDR91
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay